A doctor has issued a warning to hay fever sufferers to stock up on their medications before the first signs of pollen appear ...

Allergist and paediatrician, Dr Ruben has shared a warning to people suffering with hay fever to start taking their ...

Scientists have now deciphered the structure of the avian influenza ... Nasal Spray Flu Vaccine Candidate Shows Promise When Administered Alongside High Dose Annual Shot Aug. 15, 2024 — A unique ...

While the risk of getting bird flu is generally low for the general public, it is high for people who interact with livestock. To protect society from a pandemic, those who feed America must be ...

PHOENIX (AZFamily) — A ketamine-derived nasal spray is now available for the millions of Americans living with severe depression. The hallucinogenic drug is an option when traditional treatment ...

Flu is contagious during its 1- to 4-day incubation period and for at least a day after fever subsides. LOUISVILLE — Most people recover on their own from influenza but for some the flu and its ...

MORE:Get an online treatment plan for your cold, flu, or sinus infection in as ... we may receive a commission. Learn more. Nasal decongestant spray can help relieve sinus infection symptoms ...

In the study, scientists used a spray. Nasal vestibulitis is not usually an emergency. However, if a person with a weakened immune system develops a fever, they should go to the emergency room ...

A decongestant is a medication that helps ease nasal congestion, which happens when something irritates the lining of your nose. This can result from a cold, the flu ... a nasal spray for more ...

Johnson & Johnson's nasal spray received US FDA approval The nasal spray is used for the treatment of major depressive disorder The drug brought in sales of $780 million in 2024 The US Food and Drug ...

“The increase in flu-like symptoms has led to a noticeable uptick in patient visits compared to November 2024. The number of children presenting with symptoms such as fever, cough, sore ...

WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal spray for adults living with major depressive disorder who have had an ...